Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01663896 · ClinicalTrials.gov registry record

Observational Study of OCT in a Patients Undergoing FFR

A clinical trial of Coronary Artery Disease, sponsored by Abbott Medical Devices.

Completed
Registry status
418
Enrollment target
20
Study locations

NCT01663896 is a study of Coronary Artery Disease that has completed, run by Abbott Medical Devices. The registered enrollment target is 418 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (67% lower). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01663896, a study of Coronary Artery Disease, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
418 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to define and evaluate optical coherence tomography (OCT) stent guidance parameters through prospective data collection in percutaneous coronary intervention (PCI) procedures of de novo lesions.

Conditions Studied

Coronary Artery Disease

Interventions

  • DEVICE OCT stent guidance

Study Locations (20)

Texas

  • Heart Hospital of Austin - Austin
  • Dallas VA Medical Center - Dallas
  • University of Texas Medical Branch at Galveston - Galveston

Other

  • Med. Univ. Vienna - Vienna
  • OLV Hospital - Aalst
  • Gasthuisberg Leuven - Leuven

Kentucky

  • Central Baptist Hospital - Lexington
  • Baptist Health East - Louisville

Alabama

  • University Hospital - Univ. of Alabama at Birmingham (UAB) - Birmingham

California

  • Scripps Clinic, Green Hospital - La Jolla

Florida

  • Florida Hospital Orlando - Orlando

Georgia

  • Emory University Hospital - Atlanta

Illinois

  • Loyola University Chicago - Maywood

Trial Details

FieldValue
Enrollment Target 418 participants
Start Date 2012-12-11
Est. Completion 2015-10

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01663896

The ClinicalTrials.gov registry entry for NCT01663896 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 418 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (67% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which OCT stent guidance is the first listed.

NCT01663896 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Texas, Other, Kentucky.

Frequently Asked Questions

What is clinical trial NCT01663896 about?

NCT01663896 is a clinical study titled "Observational Study of OCT in a Patients Undergoing FFR". The purpose of this study is to define and evaluate optical coherence tomography (OCT) stent guidance parameters through prospective data collection in percutaneous coronary intervention (PCI) procedures of de novo lesions.

What is the current status of trial NCT01663896?

This trial is currently completed. The enrollment target is 418 participants. The study started on 2012-12-11. Estimated completion is 2015-10.

What conditions does trial NCT01663896 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT01663896?

The interventions under investigation include: OCT stent guidance (DEVICE).

Who is sponsoring clinical trial NCT01663896?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01663896 being conducted?

This trial has 20 study locations across Alabama, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.